• Overview
  • Eligibility
  • More info
  • Locations

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study (PART 1) (NCT03024086)

The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.
  • Drug: DWJ1252
    DWJ1252 and Placebo of Gasmotin
    • Drug: Gasmotin
      Gasmotin and Placebo of DWJ1252
      Ages eligible for Study
      19 Years and older
      Genders eligible for Study
      All
      Accepts Healthy Volunteers
      No
      Inclusion Criteria:
      • Male of female of at least 19 years old
      • Patient with functional dyspepsia met the ROME III criteria
      Exclusion Criteria:
      • Patients with previous gastrointestinal surgery
      • Patients with history of gastrointestinal bleeding, mechanical obstruction, perforation
      • Patients with history of gastrointestinal cancer

      1 locations

      Korea, Republic of (1)
      • Hanyang University Medical Center
        recruiting
        Seoul, Korea, Republic of
      Status:
      recruiting
      Type:
      Interventional
      Phase:
      Start:
      30 November, 2016
      Updated:
      14 January, 2017
      Participants:
      124
      Apply
      A girl giving information about available additional trials.

      FindMeCure helps you find, understand and join clinical trials from all over the world.

      There are more clinical trials for your condition!